NJ-based Johnson & Johnson says COVID-19 vaccine is safe, showing promising immune response
Johnson & Johnson says its COVID-19 vaccine is safe and showing a promising immune response.
•
Jan 14, 2021, 12:19 PM
•
Updated 1,658 days ago
Share:
More Stories
0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
324ds ago
Hometown Heroes in the Hudson Valley
371ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
515ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
536ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
663ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
664ds ago0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
324ds agoHometown Heroes in the Hudson Valley
371ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
515ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
536ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
663ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
664ds agoJohnson & Johnson says its COVID-19 vaccine is safe and
showing a promising immune response.
The company has reported few
side effects in early trials, things such as headache, muscle aches, and
soreness.
Data shows most volunteers
developed antibodies after 28 days.
Johnson & Johnson's
vaccine requires only one dose, while Pfizer's and Moderna's require two.
More from News 12
1:48
Paroled murder convict suffers 'cardiac event,' postponing bail hearing & potential release following new charge
1:59
Fire leaves behind heavy damage at Rye restaurant
1:18
12-year-old seriously injured in Middletown fireworks accident
MTA proposes fare hikes for buses and rails
High Noon issues recall on some products after some Celsius cans were filled with vodka seltzer
0:45
